Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferenc Banati

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biochimica Et Biophysica Acta|October 27, 2009
Epigenetic regulation of latent Epstein-Barr virus promotersMaria Takacs, Ferenc Banati, Anita Koroknai, et al.
Medical Hypotheses|February 21, 2004
EBV-associated neoplasms: alternative pathogenetic pathwaysHans Helmut Niller, Daniel Salamon, Karin Ilg, et al.
FEBS Letters|February 9, 2008
CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virusFerenc Banati, Anita Koroknai, Daniel Salamon, et al.
Plos One|August 28, 2014
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemiaEahsan Rasul, Daniel Salamon, Noemi Nagy, et al.
The Journal of General Virology|March 7, 2009
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activityDaniel Salamon, Ferenc Banati, Anita Koroknai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 29, 2003
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesisHans H Niller, Daniel Salamon, Karin Ilg, et al.
Journal of Virology|September 28, 2007
Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cellsBorbala Gerle, Anita Koroknai, György Fejer, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulationKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Virus Genes|May 19, 2007
High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1Agnes Bakos, Ferenc Banati, Anita Koroknai, et al.
Biochemical and Biophysical Research Communications|March 27, 2013
The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cellsKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochimica Et Biophysica Acta|October 27, 2009
Epigenetic regulation of latent Epstein-Barr virus promotersMaria Takacs, Ferenc Banati, Anita Koroknai, et al.
Medical Hypotheses|February 21, 2004
EBV-associated neoplasms: alternative pathogenetic pathwaysHans Helmut Niller, Daniel Salamon, Karin Ilg, et al.
FEBS Letters|February 9, 2008
CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virusFerenc Banati, Anita Koroknai, Daniel Salamon, et al.
Plos One|August 28, 2014
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemiaEahsan Rasul, Daniel Salamon, Noemi Nagy, et al.
The Journal of General Virology|March 7, 2009
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activityDaniel Salamon, Ferenc Banati, Anita Koroknai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 29, 2003
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesisHans H Niller, Daniel Salamon, Karin Ilg, et al.
Journal of Virology|September 28, 2007
Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cellsBorbala Gerle, Anita Koroknai, György Fejer, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulationKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Virus Genes|May 19, 2007
High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1Agnes Bakos, Ferenc Banati, Anita Koroknai, et al.
Biochemical and Biophysical Research Communications|March 27, 2013
The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cellsKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Pageof 2